Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils …
JHN Lindeman, H Abdul-Hussien, JH van Bockel… - Circulation, 2009 - Am Heart Assoc
Background—Doxycycline has been shown to effectively inhibit aneurysm formation in
animal models of abdominal aortic aneurysm. Although this effect is ascribed to matrix …
animal models of abdominal aortic aneurysm. Although this effect is ascribed to matrix …
[PDF][PDF] Clinical Trial of Doxycycline for Matrix Metalloproteinase-9 Inhibition in Patients With an Abdominal Aneurysm
2009 - repository.tudelft.nl
Background—Doxycycline has been shown to effectively inhibit aneurysm formation in
animal models of abdominal aortic aneurysm. Although this effect is ascribed to matrix …
animal models of abdominal aortic aneurysm. Although this effect is ascribed to matrix …
[PDF][PDF] Clinical Trial of Doxycycline for Matrix Metalloproteinase-9 Inhibition in Patients With an Abdominal Aneurysm
2009 - publications.tno.nl
Background—Doxycycline has been shown to effectively inhibit aneurysm formation in
animal models of abdominal aortic aneurysm. Although this effect is ascribed to matrix …
animal models of abdominal aortic aneurysm. Although this effect is ascribed to matrix …
Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils …
JH Lindeman, H Abdul-Hussien, JH van Bockel… - Circulation, 2009 - europepmc.org
Background Doxycycline has been shown to effectively inhibit aneurysm formation in animal
models of abdominal aortic aneurysm. Although this effect is ascribed to matrix …
models of abdominal aortic aneurysm. Although this effect is ascribed to matrix …
Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils …
JHN Lindeman, H Abdul-Hussien, JH van Bockel… - 2009 - pubmed.ncbi.nlm.nih.gov
Background Doxycycline has been shown to effectively inhibit aneurysm formation in animal
models of abdominal aortic aneurysm. Although this effect is ascribed to matrix …
models of abdominal aortic aneurysm. Although this effect is ascribed to matrix …
[引用][C] Clinical Trial of Doxycycline for Matrix Metalloproteinase-9 Inhibition in Patients With an Abdominal Aneurysm: Doxycycline Selectively Depletes Aortic Wall …
JHN LINDEMAN, H ABDUL-HUSSIEN… - … (New York, NY), 2009 - pascal-francis.inist.fr
Clinical Trial of Doxycycline for Matrix Metalloproteinase-9 Inhibition in Patients With an
Abdominal Aneurysm: Doxycycline Selectively Depletes Aortic Wall Neutrophils and Cytotoxic …
Abdominal Aneurysm: Doxycycline Selectively Depletes Aortic Wall Neutrophils and Cytotoxic …
Clinical Trial of Doxycycline for Matrix Metalloproteinase-9 Inhibition in Patients With an Abdominal Aneurysm
JHN Lindeman, H Abdul-Hussien, JH van Bockel… - Circulation, 2009 - cir.nii.ac.jp
抄録< jats: p>< jats: bold>< jats: italic> Background—</jats: italic></jats: bold> Doxycycline
has been shown to effectively inhibit aneurysm formation in animal models of abdominal …
has been shown to effectively inhibit aneurysm formation in animal models of abdominal …
[引用][C] Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: Doxycycline selectively depletes aortic wall …
L JH - Circulation, 2009 - cir.nii.ac.jp
Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an
abdominal aneurysm: Doxycycline selectively depletes aortic wall neutrophils and cytotoxic T …
abdominal aneurysm: Doxycycline selectively depletes aortic wall neutrophils and cytotoxic T …